Cramer Rosenthal Mcglynn LLC Abcam PLC Transaction History

Cramer Rosenthal Mcglynn LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.54 - $24.41 $20.9 Million - $23.7 Million	-970,365 Reduced 60.79%	625,955 $14.2 Million
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $340,096 - $659,442	-26,949 Reduced 1.66%	1,596,320 $39.1 Million
Q1 2023 May 12, 2023	SELL	$12.98 - $17.1 $1.49 Million - $1.96 Million	-114,526 Reduced 6.59%	1,623,269 $21.8 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $13.4 Million - $16.3 Million	961,092 Added 123.74%	1,737,795 $27 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $10.4 Million - $13 Million	776,703 New	776,703 $11.6 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.